Showing 17,821 - 17,840 results of 20,793 for search '"Therapy"', query time: 0.11s Refine Results
  1. 17821

    Human Umbilical Cord Perivascular Cells Prevent Tumor Growth in a Melanoma Tumor-Bearing Mouse Model and Modulate Breast Cancer and Melanoma Cells in a Cell Line-Dependent Manner I... by Lianet Lopez, Hannah Shuster-Hyman, Eden Marco, Hasna Khan, Avishai Gasner, Aleksandra Uzelac, Brandon Wyse, Poonam Mander, Mugundhine Sangaralingam, Joseph Fish, Ariel Gorodensky, Samar Mouazz, Amanda Kauffman, Denis Gallagher, Andrée Gauthier-Fisher, Clifford L. Librach

    Published 2023-01-01
    “…Our preclinical studies thus suggest that, with regards to its effects on tumor growth, systemic administration of FTM and term human umbilical cord perivascular cells may be a safe cell therapy to address the side effects of cancer.…”
    Get full text
    Article
  2. 17822

    Anti-Inflammatory Effects of Ellagic Acid on Acute Lung Injury Induced by Acid in Mice by Daniely Cornélio Favarin, Maxelle Martins Teixeira, Ednéia Lemos de Andrade, Claudiney de Freitas Alves, Javier Emilio Lazo Chica, Carlos Artério Sorgi, Lúcia Helena Faccioli, Alexandre Paula Rogerio

    Published 2013-01-01
    “…Acute lung injury (ALI) is characterized by alveolar edema and uncontrolled neutrophil migration to the lung, and no specific therapy is still available. Ellagic acid, a compound present in several fruits and medicinal plants, has shown anti-inflammatory activity in several experimental disease models. …”
    Get full text
    Article
  3. 17823

    Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease by K. El-Kersh, R. Bag, N. Bhatt, C. King, A. Waxman, F. Rischard, H. Kim, D. Cella, E. Shen, SD Nathan

    Published 2025-02-01
    “…Moreover, the calculators can provide clinicians with important prognostic information which can be used to reinforce the benefits of therapy. The risk calculators may also find utility as part of the composite allocation score of ILD-PH patients listed for lung transplant. …”
    Get full text
    Article
  4. 17824

    Effectiveness of digital health applications on the quality of life in patients with overweight or obesity: a systematic review by Melanie Mäder, Tonio Schönfelder, Ria Heinrich, Carsta Militzer-Horstmann, Patrick Timpel

    Published 2025-01-01
    “…., health status, illness duration, QoL) or patient-related factors (e.g., therapy monitoring, adherence, health literacy). To date, there is no systematic review addressing the effectiveness of DiHA on the QoL in patients with overweight or obesity. …”
    Get full text
    Article
  5. 17825

    Pathogenic and Genetic Characteristics of Helicobacter Pylori, and its Relationship with Drug-Resistance by Nilgün Uyduran Ünal, Adnan Barutçu, Toğrul Nagiyev, Mehmet Ağın, Tülay Kandemir, Oğuz Üsküdar, Figen Doran, Fatih Köksal, Gökhan Tümgör

    Published 2024-10-01
    “…High resistance was found against clarithromycin in the standard triple therapy regimen used in children for treating H. pylori infection.…”
    Get full text
    Article
  6. 17826
  7. 17827

    Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: R... by John Porter, Donald K. Bowden, Marina Economou, Jacques Troncy, Arnold Ganser, Dany Habr, Nicolas Martin, Adam Gater, Diana Rofail, Linda Abetz-Webb, Helen Lau, Maria Domenica Cappellini

    Published 2012-01-01
    “…HRQOL and satisfaction, adherence, and persistence to iron chelation therapy (ICT) data were collected at baseline and end of study using the Medical Outcomes Short-Form 36-item Health Survey (SF-36v2) and the Satisfaction with ICT Questionnaire (SICT). …”
    Get full text
    Article
  8. 17828

    Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization by Silvia Codenotti, Michela Asperti, Maura Poli, Luisa Lorenzi, Alberto Pietrantoni, Matteo Cassandri, Francesco Marampon, Alessandro Fanzani

    Published 2025-02-01
    “…Therefore, stimulating CHO depletion via SREBP2 and MVP inhibition may represent a viable option to improve the combination therapy protocol, especially in pAkt1-positive RMS.…”
    Get full text
    Article
  9. 17829

    Evaluating ChatGPT-4o as a decision support tool in multidisciplinary sarcoma tumor boards: heterogeneous performance across various specialties by Tekoshin Ammo, Vincent G. J. Guillaume, Ulf Krister Hofmann, Norma M. Ulmer, Nina Buenting, Florian Laenger, Justus P. Beier, Tim Leypold

    Published 2025-01-01
    “…Assessments were graded on a Likert scale from 1 (completely disagree) to 5 (completely agree) across five categories: understanding, therapy/diagnostic recommendation, aftercare recommendation, summarization, and support tool effectiveness.ResultsThe mean score for ChatGPT-4o performance was 3.76, indicating moderate effectiveness. …”
    Get full text
    Article
  10. 17830

    Development and progression association of various ophthalmic pathologies with the gut microbiome state (literature review) by G.N. Rezbaeva, A.E. Babushkin, O.I. Orenburkina, I.A. Gimranova

    Published 2023-11-01
    “…This suggests the potential use of this indicator as a non-invasive biomarker during differential diagnosis, as well as its introduction for ophthalmic therapy purposes. In particular, the association between the gut microbiota and the eyes can serve as a basis for the technique development aimed at the treatment of a number of eye diseases. …”
    Get full text
    Article
  11. 17831

    RNA m6A-mediated post-transcriptional repression of glucocorticoid receptor in LPS-activated Kupffer cells on broilers by Yulan Zhao, Yidan Jiang, Yue Feng, Ruqian Zhao

    Published 2025-01-01
    “…Our study indicates successive roles of RNA m6A modification in the down regulation of GR expression, which provides new drug targets for epigenetic therapy of liver inflammation.…”
    Get full text
    Article
  12. 17832

    Comparison of phenotypic and genetic traits of ESBL-producing UPEC strains causing recurrent or single episode UTI in postmenopausal women by Michelle Kalu, Peter Jorth, Annie Wong-Beringer

    Published 2025-02-01
    “…These results emphasize the potential microbial contributions to recurrence in postmenopausal women and warrant future investigations on the impact of antibiotic therapy and host response on IBC-supportive UPEC virulence.…”
    Get full text
    Article
  13. 17833

    Clinical Practice Guideline for the Treatment of Traumatic Shock Patients from the Korean Society of Traumatology by Pil Young Jung, Byungchul Yu, Chan-Yong Park, Sung Wook Chang, O Hyun Kim, Maru Kim, Junsik Kwon, Gil Jae Lee, Korean Society of Traumatology (KST) Clinical Research Group

    Published 2020-03-01
    “…For hypovolemic patients with coagulopathy non-responsive to primary therapy, the use of fibrinogen concentrate, cryoprecipitate, or recombinant factor VIIa can be considered (2C). …”
    Get full text
    Article
  14. 17834

    Cost drivers associated with autologous stem-cell transplant (ASCT) in patients with relapsed/refractory diffuse large B-cell lymphoma in a Japanese real-world setting: A structura... by Saaya Tsutsué, Shinichi Makita, Hiroya Asou, Shingo Wada, Wen Shi Lee, Dilinuer Ainiwaer, Koki Idehara, Sona-Sanae Aoyagi, Seok-Won Kim, Todd Taylor

    Published 2025-01-01
    “…A total of 15 patients (13.89%) received subsequent therapies. The most frequent subsequent therapy was GDP-based with or without rituximab (n = 8, 7.41%). …”
    Get full text
    Article
  15. 17835

    SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin by Shihan Qian, Jingjing Zhu, Qing Han, Huang Cheng, Huaibin Zhou

    Published 2025-01-01
    “…Manipulating SHP2 expression or its target protein β-catenin may offer a novel approach to TNBC therapy.…”
    Get full text
    Article
  16. 17836

    The Impact of Specific Gut Microbiota Metabolites on Chronic Kidney Disease Progression: Novel Diagnostic Biomarkers and Therapeutic Targets by Daria Dąbkowska, Agnieszka Mioskowska, Joanna Szydziak, Aleksandra Hrapkowicz, Kinga Janowska, Olga Szeidl, Dominika Rehan, Julia Wołoszczak

    Published 2025-01-01
    “…These metabolites can aid in both diagnosing the condition and predicting its progression. Emerging therapies that manipulate the microbiota—through approaches such as dietary changes, probiotics, modulation of bacterial metabolites, fecal microbiota transplantation, or the use of genetically modified bacteria—have shown promising results. …”
    Get full text
    Article
  17. 17837

    Adverse health effects after breast cancer up to 14 years after diagnosis by Marianne J. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette Berendsen, Daan Brandenbarg, Anneriet Dassen, Agnes Jager, Jacqueline Hugtenburg, Gerda van der Weele

    Published 2025-02-01
    “…Osteoporosis and chest symptoms were associated with hormone therapy; osteoporosis and skin infections with chemotherapy and lymphedema and skin infections with axillary dissection. …”
    Get full text
    Article
  18. 17838
  19. 17839
  20. 17840

    Imagery Rescripting (ImRs) and Eye Movement Desensitization and Reprocessing (EMDR) as treatment of childhood-trauma related post-traumatic stress disorder (Ch-PTSD) in adults: eff... by Martine Daniëls, Marie-Louise Meewisse, Annet Nugter, Sophie A. Rameckers, Eva Fassbinder, Arnoud Arntz

    Published 2025-12-01
    “…Schema Modes are an operationalization of personality pathology according to schema therapy and can be measured with the Schema Mode Inventory (SMI). …”
    Get full text
    Article